Profile
Isabel Kalofonos currently works at Crinetics Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Ms. Kalofonos also formerly worked at Fulcrum Therapeutics, Inc., as Chief Commercial Officer in 2024, ImmunoGen, Inc., as Chief Commercial Officer & Senior Vice President from 2023 to 2024, and Galderma Holding SA, as Senior VP & Head-Prescription Business from 2020 to 2023.
Ms. Kalofonos received her Masters Business Admin degree from Babson College and undergraduate degree from Pontificia Universidad Javeriana.
Former positions of Isabel Kalofonos
| Companies | Position | End |
|---|---|---|
| CRINETICS PHARMACEUTICALS | Corporate Officer/Principal | 31/08/2026 |
| FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 29/09/2024 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 31/07/2024 |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and distributes dermatological & skin care products | Corporate Officer/Principal | 28/02/2023 |
Training of Isabel Kalofonos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pontificia Universidad Javeriana
Pontificia Universidad Javeriana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and distributes dermatological & skin care products | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
- Stock Market
- Insiders
- Isabel Kalofonos
















